Literature DB >> 1485175

Oral mesna: a review.

M P Goren1.   

Abstract

Oral administration of mesna can facilitate outpatient ifosfamide therapy. Blood and urinary mesna concentrations are more steady and prolonged after oral delivery compared with after intravenous delivery. The incidence of hematuria observed during partial oral mesna therapy is no greater than that during intravenous mesna therapy. The pharmacology, pharmacokinetics, efficacy, safety, and reported schedules of administration are reviewed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1485175

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  5 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.

Authors:  T Kerbusch; J de Kraker; H J Keizer; J W van Putten; H J Groen; R L Jansen; J H Schellens; J H Beijnen
Journal:  Clin Pharmacokinet       Date:  2001-01       Impact factor: 6.447

2.  Failed back surgery syndrome: a new strategy by the epidural injection of MESNA.

Authors:  M Carassiti; A Di Martino; A Centonze; C C Quattrocchi; A Caldaria; F Agrò; V Denaro
Journal:  Musculoskelet Surg       Date:  2017-11-02

3.  Mesna (2-mercaptoethane sodium sulfonate) functions as a regulator of myeloperoxidase.

Authors:  Roohi Jeelani; Seyedehameneh Jahanbakhsh; Hamid-Reza Kohan-Ghadr; Mili Thakur; Sana Khan; Sarah R Aldhaheri; Zhe Yang; Peter Andreana; Robert Morris; Husam M Abu-Soud
Journal:  Free Radic Biol Med       Date:  2017-05-25       Impact factor: 7.376

Review 4.  Antineoplastic agents. Drug interactions of clinical significance.

Authors:  E van Meerten; J Verweij; J H Schellens
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

Review 5.  Ifosfamide clinical pharmacokinetics.

Authors:  T Wagner
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.